National Advertising Division Refers Virgin Scent to Regulatory Authorities for Failure to Respond to Art Naturals NAD+ Dietary Supplement Inquiry
New York, NY, November 5, 2025 – Following an inquiry by competitor Reus Research, LLC, BBB National Programs’ National Advertising Division (NAD) will refer Virgin Scent, Inc. to the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) for failure to respond to challenged express and implied claims regarding the ingredients in its Art Naturals NAD+ dietary supplement.
Virgin Scent, doing business as ArtNaturals, markets an NAD+ dietary supplement that also contains green tea leaf, turmeric root, and grape seed. Reus, a dietary supplement company, markets competing NAD+ products, including Cata-Kor NAD+ Core and Cata-Kor NAD+ Advanced, and claims Virgin Scent overstates its ingredient amounts. The challenged Virgin Scent claims appear on product labels, the ArtNaturals website, Amazon product pages, and social media.
Despite repeated outreach attempts, Virgin Scent did not submit a substantive written response to NAD’s inquiry. Therefore, NAD will refer the matter to the appropriate government agency, in this case the FTC and the FDA, and to the platforms on which Virgin Scent’s advertising appeared and with which NAD has a reporting relationship.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.
Virgin Scent, doing business as ArtNaturals, markets an NAD+ dietary supplement that also contains green tea leaf, turmeric root, and grape seed. Reus, a dietary supplement company, markets competing NAD+ products, including Cata-Kor NAD+ Core and Cata-Kor NAD+ Advanced, and claims Virgin Scent overstates its ingredient amounts. The challenged Virgin Scent claims appear on product labels, the ArtNaturals website, Amazon product pages, and social media.
Despite repeated outreach attempts, Virgin Scent did not submit a substantive written response to NAD’s inquiry. Therefore, NAD will refer the matter to the appropriate government agency, in this case the FTC and the FDA, and to the platforms on which Virgin Scent’s advertising appeared and with which NAD has a reporting relationship.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.